申请人:Gilead Sciences, Inc.
公开号:US08324179B2
公开(公告)日:2012-12-04
The invention provides unsaturated phosphonates of Formula I or a tautomer or pharmaceutically acceptable salt thereof, as described herein, as well as pharmaceutical compositions comprising the compounds, and therapeutic methods comprising administering the compounds. The compounds have anti-viral properties and are useful for treating viral infections (e.g. HCV) in animals (e.g. humans).
本发明提供了公式I或其互变异构体或药学上可接受的盐的不饱和膦酸酯,以及包含该化合物的制药组合物和包括给予该化合物的治疗方法。该化合物具有抗病毒性能,可用于治疗动物(例如人类)的病毒感染(例如HCV)。